{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/fr\/","title":"Les biomarqueurs de l\u2019asthme grave permettraient une meilleure orientation des nouveaux agents - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rx4MEnxFU1\"><a href=\"https:\/\/themedicalxchange.com\/fr\/2016\/05\/25\/conference-internationale-de-lamerican-thoracic-3\/\">Les biomarqueurs de l\u2019asthme grave permettraient une meilleure orientation des nouveaux agents<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/fr\/2016\/05\/25\/conference-internationale-de-lamerican-thoracic-3\/embed\/#?secret=rx4MEnxFU1\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Les biomarqueurs de l\u2019asthme grave permettraient une meilleure orientation des nouveaux agents\u00a0\u00bb &#8212; The Medical Xchange\" data-secret=\"rx4MEnxFU1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2016\/05\/2359_ATS_2016_FR_fig1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"San Francisco \u2013 Gr\u00e2ce aux donn\u00e9es issues du Programme de recherche sur l\u2019asthme grave (Severe Asthma Research Program [SARP]), il serait possible d\u2019orienter les plus r\u00e9cents agents cibl\u00e9s en fonction des facteurs physiopathologiques sous-jacents corr\u00e9l\u00e9s aux exacerbations fr\u00e9quentes et difficiles \u00e0 faire c\u00e9der chez les patients asthmatiques. Les donn\u00e9es de ce programme, qui ont \u00e9t\u00e9 pr\u00e9sent\u00e9es lors de la Conf\u00e9rence internationale de l\u2019ATS de cette ann\u00e9e, portent \u00e0 croire que des biomarqueurs bien pr\u00e9cis pourraient permettre l\u2019utilisation de nouveaux agents efficaces, quoique co\u00fbteux, pour r\u00e9duire \u00e0 la fois les risques d\u2019incidents mena\u00e7ant le pronostic vital et la surconsommation des ressources en sant\u00e9."}